Determination of the Binding Mode of Thienopyrimidinedione Antagonists to the Human Gonadotropin Releasing Hormone Receptor Using Structure-Activity Relationships, Site-Directed Mutagenesis, and Homol
We have investigated the specific interactions of a series thienopyrimidinediones with the gonadotropin-releasing hormone receptor (GnRH-R). Competitive radioligand binding assays were used to determine theeffect of several mutants on nonpeptide binding. Distinct interactions were observed in two separateregions: the N-terminal end of TM7 and the C-terminal end of TM6. The effects of mutants at D302(7.32)and H306(7.36) suggest that these residues are part of a hydrogen-bond network important for anchoring thenonpeptides. Structure-activity relationships indicated urea substituents on the 6-(4-aminophenyl) groupwith a trans conformational preference bind with high affinity and are sensitive to D302(7.32) mutations.Another interaction area was found between the N-benzyl-N-methylamino substituent and L300(6.68) andY290(6.58). These interaction sites facilitated the derivation of a model in which a representative member ofthe series was docked into GnRH-R. The model is consistent with known SAR and illuminates inconsistencieswith previous hypotheses regarding how this series interacts with the receptor.